1 / 4

Specialty CRO's Market 2018 Drivers, Challenges, Key Regions

Specialty clinical research organizations are distinct service providers in clinical research domain with expertise based on different criteria.<br>

rushi12
Download Presentation

Specialty CRO's Market 2018 Drivers, Challenges, Key Regions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Specialty CRO's Market - Size, Share, Growth, Specialty CRO's Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Outlook, and Opportunity Analysis, 2018-2026 Specialty clinical research organizations are distinct service providers in clinical research domain with expertise based on different criteria. Earlier pharmaceutical and biotech firms, which are research driven had conducted majority of the clinical research. However, since last two decades, most of the clinical trial tasks such as lead discovery, preclinical studies, and different phases of clinical trials have been slowly outsourced to external clinical research firms. These firms gained operational expertise, geographic reach, and necessary infrastructure to efficiently conduct different clinical research activities, in order to speed up the drug discovery process. This helps pharmaceutical and biotech firms to launch novel therapies in the quickest possible time. Specialty clinical research organizations goes one step ahead from conventional multitasking clinical research organization. They gained proficiency in one or more niche segments amongst the large ecosystem of clinical research industry, thereby offering improved quality of service to the sponsors. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1627 Specialty CROs offers advantage over conventional CROs, as they are focused on specific area of application based either on therapeutic area or specialty service they offer. Specialty CROs offer solutions to the problems in clinical research such as increasing developmental cost, high rate of lead candidate failure during clinical trial, and stringent regulatory demands such as clinical protocols across the globe. Although it is still considered as an emerging model across the globe, it is gaining significant traction in the Asian economies. Specialty CROs are playing a major role in mid-size or small pharmaceutical and biotech firms, which are working in niche area and has unique clinical research needs. Moreover, they offer cost effective and economical services as compared with large CROs. Large CROs are increasingly focusing on approaching specialty CROs, as they find it difficult to cater to unique problems. Regional Insights

  2. On the basis of geography, global specialty CROs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the market over the forecast period, owing to the fact that pharmaceutical and biotech companies in this region spends significant amount on research and development, in order to bring novel therapies to the market. As per the estimation of Pharmaceutical Research and Manufacturers of America (PhRMA) in 2017, on an average the pharmaceutical industry invested around US$ 0.8 billion to US$ 1.7 billion on research and development. According to the U.S. National Library for Medicine, by January 2018, around 264,099 clinical studies were registered, which included all the healthcare product spectrum. Asia Pacific is expected to provide lucrative opportunities for market growth due to the cost effective services offered to the CROs in this region, large number of skilled human resources, and availability of large patient pool. Report includes chapters which deeply display the following deliverable about industry : • Specialty CRO's Market Research Objective and Assumption • Specialty CRO's Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Specialty CRO's Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Specialty CRO's Market, By Regions • Specialty CRO's Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Specialty CRO's Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Specialty CRO's Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Specialty CRO's Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Competitive Landscape

  3. Some of key players operating in the specialty CROs market include Charles River Laboratories, Profil Abiogenesis Clinpharm, Accell Clinical Research, Accelovance, Aclires, Acquipharma, Cytespace Africa, DATATRAK International, Afraxis, David H Murdock Research Institute, DaVita Clinical Research, Gateway Pharmacology Laboratories, SAGE Labs, and Velesco Pharmaceutical Services. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1627 Market Taxonomy On the basis of therapeutic area, the global specialty CROs market is segmented into: Oncology Cardiovascular Disease Diabetes Others • • • • On the basis of service, the global specialty CROs market is segmented into: Clinical Trial Management Service Clinical Data Management Service Pharmacovigilance Service Regulatory Affairs/Medical Writing Others • • • • • On the basis of region, the global specialty CROs market is segmented into: North America Latin America Europe Asia Pacific Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

  4. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related